FDA GMP inspection readiness preparation

FDA & TGA GMP Inspection Readiness

FDA Inspection Readiness

Inspection readiness is not something you build in the weeks before an inspector arrives — it is a continuous state. We prepare pharmaceutical manufacturers for FDA and TGA GMP inspections through structured readiness programmes that identify gaps, fix them, and ensure your team responds confidently when inspectors arrive.

FDA + TGA

Inspection experience

A1 Rating

TGA GMP compliance achieved

Mock inspections

Realistic rehearsal

483 response

Post-inspection support

"Inspection readiness is a habit, not an event. By the time the inspector arrives, the preparation is either done or it isn't."

The most common source of FDA findings is not missing documentation — it is employees who cannot explain the procedures they are supposed to follow.

What we cover

Six areas of FDA inspection preparation

Our readiness programmes cover every dimension of an FDA GMP inspection — from documentation to people to post-inspection response.

Documentation audit

We conduct a systematic pre-inspection review of your batch records, SOPs, change controls, CAPA files and laboratory raw data — identifying gaps before the inspector does.

  • Batch record completeness review
  • SOP currency and practice alignment
  • Change control impact assessment
  • CAPA effectiveness and closure status
  • Lab data integrity check

Mock FDA inspection

A structured simulation of an FDA inspection covering the areas most likely to draw scrutiny. Our consultant plays the role of investigator — examining documents, interviewing staff and issuing findings.

  • Full facility walkthrough
  • Document request simulation
  • Staff interview preparation
  • 483 observation identification
  • Written findings and prioritised remediation plan

Quality systems review

Inspectors assess whether your quality system functions in practice, not just on paper. We review management review engagement, internal audit cadence, supplier qualification and OOS investigation processes.

  • Management review records
  • Internal audit programme and findings
  • Supplier qualification and monitoring
  • OOS and deviation investigation processes
  • CAPA root cause and effectiveness

Back-room team preparation

The back-room team gathers documents requested during inspection. Poor back-room organisation is a consistent source of observation-worthy delays. We prepare your team for rapid, accurate document retrieval.

  • Document retrieval procedure
  • Back-room roles and responsibilities
  • Response time targets and rehearsal
  • Communication protocol with front-room
  • Real-time document tracking setup

Staff interview training

Inspectors interview operators, supervisors and management. Employees who cannot explain their own procedures are the most common root cause of FDA findings. We train your people to answer confidently and accurately.

  • Role-specific interview preparation
  • Common inspector question scenarios
  • How to respond to leading questions
  • Escalation protocol for complex questions
  • Post-interview debrief process

483 and Warning Letter response

If you have already received a 483 or Warning Letter, we develop a credible CAPA-based response strategy — addressing root causes, not just observations — and prepare the written response to FDA.

  • 483 observation root cause analysis
  • CAPA development and timelines
  • Warning Letter response drafting
  • Commitments tracking and follow-up
  • Re-inspection preparation

Who prepares you

Consultants who have been in the inspection room

Leah Thompson has successfully navigated routine TGA and FDA audits and improved GMP compliance to an A1 TGA rating — the highest awarded under the Therapeutic Goods Act. Rani Sabhavat brings deep CMC and quality systems experience across 21 CFR Parts 210, 211 and 820. Your inspection preparation is led by people who know exactly what inspectors look for.

Meet the team

FAQ

FDA inspection readiness — common questions

General information only — not legal or regulatory advice.

How long before an FDA inspection should we begin preparation?

Ideally, inspection readiness is maintained continuously rather than triggered by an inspection notice. For companies starting from scratch, allow at least 3–6 months for a structured readiness programme. If you have received an inspection notice, contact us immediately — we will assess what is achievable in the available time.

What are the most common FDA inspection findings?

The most frequent observations relate to CAPA systems (inadequate root cause analysis or lack of effectiveness checks), laboratory controls (data integrity, OOS investigation), production records (incomplete or inconsistent batch records), and quality management systems (management review, internal audits). Our pre-inspection audit specifically targets these areas.

Do you support TGA inspections as well as FDA?

Yes. We provide inspection readiness programmes for both FDA and TGA GMP audits. Leah Thompson has successfully navigated routine TGA and FDA audits and achieved an A1 TGA GMP rating — the highest awarded under the Therapeutic Goods Act.

What happens after an inspection if we receive observations?

We help you develop a 483 response or Warning Letter response strategy — identifying root causes, building credible CAPAs with realistic timelines, and drafting the response to FDA. We also prepare you for any follow-up inspection.

Don't wait for the notice

Start your inspection readiness programme today

A pre-inspection audit costs a fraction of a 483 remediation. Book a free consultation and we will outline a readiness programme for your facility.